Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 28 source : Www.biospace.com save search
Publications Validate Clinical Safety and Efficacy of Shockwave Intravascular Lithotripsy
Published: 2021-06-28 (Crawled : 20:00) - biospace.com/
SWAV | $328.41 -0.06% -0.06% 890K
|
Health Technology
|
| O: 1.61%
H: 2.42%
C: 2.17%
publication
AstraZeneca, Sanofi’s Monoclonal RSV Antibody Shows Promising Safety in Infants
Published: 2021-06-28 (Crawled : 19:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
antibody
Novelion Provides Update on Final Distribution to Registered Shareholders
Published: 2021-06-28 (Crawled : 19:00) - biospace.com/
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -2.13%
H: 0.62%
C: -3.26%
distribution
Vincerx Pharma Announces Inclusion in Russell 3000® and Microcap® Indexes
Published: 2021-06-28 (Crawled : 19:00) - biospace.com/
VINC | $0.955 9.9% 9.01% 410K
|
|
| O: 0.26%
H: 5.88%
C: 3.63%
pharma
New Soliqua data shows improved blood sugar control without weight gain versus premixed insulin
Published: 2021-06-28 (Crawled : 18:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
blood insulin
Humanigen Inc. Added to Russell 3000(R) Index
Published: 2021-06-28 (Crawled : 17:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: -0.83%
H: 0.84%
C: -2.64%
Clinical Catch-Up: June 21-25
Published: 2021-06-28 (Crawled : 17:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.7%
H: 0.48%
C: -3.58%
AVXL | $3.68 0.0% 1.4M
|
Health Technology
|
| O: 20.0%
H: 6.06%
C: -2.83%
COVID-19 News: Delta Variant a Cause for Concern and Other Topics
Published: 2021-06-28 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.14%
H: 0.38%
C: -0.26%
covid covid-19
Medtronic InPen™ Real-World Data and Extended Infusion Set* Pivotal Trial Results Demonstrate Strong Clinical Outcomes and Positive User Experience
Published: 2021-06-28 (Crawled : 17:00) - biospace.com/
MDT | $81.29 0.89% 0.0% 5.2M
|
Health Technology
|
| O: 0.29%
H: 0.1%
C: -1.24%
positive trial trial results
Vertex Announces National Reimbursement Agreement in France for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) and SYMKEVI® (tezacaftor/ivacaftor) for Eligible Cystic Fibrosis Patients
Published: 2021-06-28 (Crawled : 16:00) - biospace.com/
VRTX | $404.93 1.25% 1.43% 1.1M
|
Health Technology
|
| O: 1.37%
H: 0.88%
C: 0.42%
fibrosis cystic fibrosis
Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors
Published: 2021-06-28 (Crawled : 16:00) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.25%
H: 0.75%
C: -0.23%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.24%
H: 2.98%
C: 2.4%
CABA | $13.31 -0.08% -0.08% 760K
|
Health Technology
|
| O: 1.87%
H: 8.33%
C: 6.04%
biopharma
Eiger BioPharmaceuticals Announces Presentation of Positive Phase 2 Results of Avexitide in Congenital Hyperinsulinism at the American Diabetes Association Virtual 81st Scientific Session
Published: 2021-06-28 (Crawled : 16:00) - biospace.com/
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 4.84%
H: 5.28%
C: -1.65%
presentation diabetes phase 2 biopharma positive phase 2 results results insulin
AngelMed Announces FDA Approval of the Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events
Published: 2021-06-28 (Crawled : 16:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -0.06%
H: 1.2%
C: -2.88%
fda fda approval approval syndros
CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiving Surgery Plus Radiotherapy in a Landmark Head and Neck Cancer Phase 3 Study
Published: 2021-06-28 (Crawled : 16:00) - biospace.com/
CVM | $1.47 -2.65% 0.0% 190K
|
Health Technology
|
| O: 7.26%
H: 1.41%
C: -49.11%
immunotherapy therapy cancer phase 3 iot cel
LivaNova to Host Conference Call for Second Quarter 2021 Results
Published: 2021-06-28 (Crawled : 14:15) - biospace.com/
LIVN | $55.01 1.85% 1.82% 640K
|
Health Technology
|
| O: -0.01%
H: 0.44%
C: -0.58%
results conference
Avinger Announces Key Opinion Leader Presentations at Vascular Conferences in Germany
Published: 2021-06-28 (Crawled : 14:00) - biospace.com/
AVGR | $3.785 -7.67% 3.3K
|
Health Technology
|
| O: 1.71%
H: 0.84%
C: -4.2%
presentation conference germany
Dyadic’s C1 Production Platform Utilized in ZAPI Study Published in “VACCINES” a Leading Peer-Reviewed Scientific Journal
Published: 2021-06-28 (Crawled : 14:00) - biospace.com/
DYAI A | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: 1.63%
H: 4.29%
C: -0.8%
vaccine
Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel for Acute Myocardial Infarction
Published: 2021-06-28 (Crawled : 14:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.23%
H: 1.84%
C: -1.61%
phase 3 pharma
Kate Cronin to Join Moderna as Chief Brand Officer on July 12
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
WPP | $49.63 1.02% 0.0% 250K
|
Commercial Services
|
| O: -0.76%
H: 0.09%
C: -1.49%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 1.39%
H: 0.94%
C: -0.03%
FDA Action Alert: Vericel and Provention Bio
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
VCEL | $46.38 2.2% 2.16% 360K
|
Health Technology
|
| O: 0.74%
H: 1.18%
C: -0.13%
fda
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.